Navigation Links
Inflammatory Bowel Disease Global Clinical Trials Review, H2, 2012
Date:9/6/2012

NEW YORK, Sept. 6, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Inflammatory Bowel Disease Global Clinical Trials Review, H2, 2012

http://www.reportlinker.com/p0611576/Inflammatory-Bowel-Disease-Global-Clinical-Trials-Review-H2-2012.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Discovery_and_Development

Inflammatory Bowel Disease Global Clinical Trials Review, H2, 2012

Summary GlobalData's clinical trial report, "Inflammatory Bowel Disease Global Clinical Trials Review, H2, 2012" provides data on the Inflammatory Bowel Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Inflammatory Bowel Disease. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Inflammatory Bowel Disease. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more- Obtain discontinued trial listing for trials across the globe- Espy the commercial landscape of the major Universities / Institutes / Hospitals or CompaniesTable of ContentsTable of Contents 2List of Tables 5List of Figures 7Introduction 8Inflammatory Bowel Disease 8Report Guidance 8Clinical Trials by Region 9Clinical Trials by Country 10Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12Top Five Countries Contributing to Clinical Trials in Europe 13Top Countries Contributing to Clinical Trials in North America 14Top Countries Contributing to Clinical Trials in Middle East and Africa 15Top Countries Contributing to Clinical Trials in Central and South America 16Clinical Trials by BRIC Nations 17Clinical Trials by G7 Nations 18Clinical Trials in G7 Nations by Trial Status 19Clinical Trials by E7 Nations 20Clinical Trials in E7 Nations by Trial Status 21Clinical Trials by Phase 22In Progress Trials by Phase 23Clinical Trials by Trial Status 24Unaccomplished Trials of Inflammatory Bowel Disease 25Subjects Recruited Over a Period of Time 32Prominent Sponsors 33Top Companies Participating in Inflammatory Bowel Disease Therapeutics Clinical Trials 35Prominent Drug Comparison 37Clinical Trial Profiles 38Clinical Trial Overview of Top Companies 38Abbott Laboratories 38Clinical Trial Overview of Abbott Laboratories 38Merck & Co., Inc. 40Clinical Trial Overview of Merck & Co., Inc. 40Pfizer Inc. 42Clinical Trial Overview of Pfizer Inc. 42UCB S.A. 44Clinical Trial Overview of UCB S.A. 44GlaxoSmithKline plc 45Clinical Trial Overview of GlaxoSmithKline plc 45UCB, Inc. 46Clinical Trial Overview of UCB, Inc. 46Johnson & Johnson 47Clinical Trial Overview of Johnson & Johnson 47Alba Therapeutics Corporation 48Clinical Trial Overview of Alba Therapeutics Corporation 48AstraZeneca PLC 49Clinical Trial Overview of AstraZeneca PLC 49Sanofi 50Clinical Trial Overview of Sanofi 50Teva Pharmaceutical Industries Limited 51Clinical Trial Overview of Teva Pharmaceutical Industries Limited 51Alvine Pharmaceuticals, Inc. 52Clinical Trial Overview of Alvine Pharmaceuticals, Inc. 52Cytokine PharmaSciences, Inc. 53Clinical Trial Overview of Cytokine PharmaSciences, Inc. 53Osiris Therapeutics, Inc. 54Clinical Trial Overview of Osiris Therapeutics, Inc. 54Bristol-Myers Squibb Company 55Clinical Trial Overview of Bristol-Myers Squibb Company 55Given Imaging Ltd. 56Clinical Trial Overview of Given Imaging Ltd. 56Zeria Pharmaceutical Co Ltd 57Clinical Trial Overview of Zeria Pharmaceutical Co Ltd 57Elan Pharmaceuticals, Inc 58Clinical Trial Overview of Elan Pharmaceuticals, Inc 58Dr. Falk Pharma GmbH 59Clinical Trial Overview of Dr. Falk Pharma GmbH 59Janssen Biotech, Inc. 60Clinical Trial Overview of Janssen Biotech, Inc. 60Clinical Trial Overview of Top Universities / Institutes / Hospitals 61Tel-Aviv Sourasky Medical Center 61Clinical Trial Overview of Tel-Aviv Sourasky Medical Center 61Academic Medical Centre 62Clinical Trial Overview of Academic Medical Centre 62University of Pittsburgh 63Clinical Trial Overview of University of Pittsburgh 63Indiana University 64Clinical Trial Overview of Indiana University 64Mayo Clinic 65Clinical Trial Overview of Mayo Clinic 65Hyogo College Of Medicine 66Clinical Trial Overview of Hyogo College Of Medicine 66Vanderbilt University 67Clinical Trial Overview of Vanderbilt University 67Beth Israel Deaconess Medical Center 68Clinical Trial Overview of Beth Israel Deaconess Medical Center 68VU University Medical Center 69Clinical Trial Overview of VU University Medical Center 69University of Alberta 70Clinical Trial Overview of University of Alberta 70University of Zurich 71Clinical Trial Overview of University of Zurich 71Children's Hospital Boston 72Clinical Trial Overview of Children's Hospital Boston 72Keio University 73Clinical Trial Overview of Keio University 73Tokyo Medical and Dental University 74Clinical Trial Overview of Tokyo Medical and Dental University 74Assistance Publique - Hopitaux de Paris 75Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 75Hadassah Medical Organization 76Clinical Trial Overview of Hadassah Medical Organization 76Northwestern University 77Clinical Trial Overview of Northwestern University 77The University of British Columbia 78Clinical Trial Overview of The University of British Columbia 78Asan Medical Center 79Clinical Trial Overview of Asan Medical Center 79University of Erlangen-Nurnberg 80Clinical Trial Overview of University of Erlangen-Nurnberg 80Five Key Clinical Profiles 81Appendix 213Abbreviations 213Definitions 213Research Methodology 214Secondary Research 214About GlobalData 215Contact Us 215Disclaimer 215Source 216

List of Tables

Inflammatory Bowel Disease Therapeutics Market, Global, Clinical Trials by Zone, 2012* 9Inflammatory Bowel Disease Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 10Inflammatory Bowel Disease Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 11Inflammatory Bowel Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012* 12Inflammatory Bowel Disease Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 13Inflammatory Bowel Disease Therapeutics Clinical Trials, North America, Top Countries, 2012* 14Inflammatory Bowel Disease Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012* 15Inflammatory Bowel Disease Therapeutics Clinical Trials, Central and South America, Top Countries, 2012* 16Inflammatory Bowel Disease Therapeutics Clinical Trials, BRIC Countries, 2012* 17Inflammatory Bowel Disease Therapeutics Clinical Trials, G7 Countries, 2012* 18Inflammatory Bowel Disease Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 19Inflammatory Bowel Disease Therapeutics Clinical Trials, E7 Countries, 2012* 20Inflammatory Bowel Disease Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 21Inflammatory Bowel Disease Therapeutics Market, Global, Clinical Trials by Phase, 2012* 22Inflammatory Bowel Disease Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 23Inflammatory Bowel Disease Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 24Inflammatory Bowel Disease Therapeutics Market, Global, Suspended Clinical Trials, 2012* 25Inflammatory Bowel Disease Therapeutics Market, Global, Withdrawn Clinical Trials, 2012* 26Inflammatory Bowel Disease Therapeutics Market, Global, Terminated Clinical Trials, 2012* 27Inflammatory Bowel Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011 32Inflammatory Bowel Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 34Inflammatory Bowel Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 36Inflammatory Bowel Disease Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 37Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2012* 38Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2012* 40Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012* 42Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by UCB S.A., 2012* 44Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2012* 45Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by UCB, Inc., 2012* 46Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2012* 47Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Alba Therapeutics Corporation, 2012* 48Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2012* 49Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2012* 50Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Teva Pharmaceutical Industries Limited, 2012* 51Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Alvine Pharmaceuticals, Inc., 2012* 52Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Cytokine PharmaSciences, Inc., 2012* 53Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Osiris Therapeutics, Inc., 2012* 54Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2012* 55Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Given Imaging Ltd., 2012* 56Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Zeria Pharmaceutical Co Ltd, 2012* 57Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Elan Pharmaceuticals, Inc, 2012* 58Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Dr. Falk Pharma GmbH, 2012* 59Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Janssen Biotech, Inc., 2012* 60Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Tel-Aviv Sourasky Medical Center, 2012* 61Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Medical Centre, 2012* 62Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2012* 63Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Indiana University, 2012* 64Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2012* 65Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Hyogo College Of Medicine, 2012* 66Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt University, 2012* 67Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Beth Israel Deaconess Medical Center, 2012* 68Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by VU University Medical Center, 2012* 69Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Alberta, 2012* 70Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Zurich, 2012* 71Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Children's Hospital Boston, 2012* 72Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Keio University, 2012* 73Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Tokyo Medical and Dental University, 2012* 74Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2012* 75Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Hadassah Medical Organization, 2012* 76Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2012* 77Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of British Columbia, 2012* 78Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Asan Medical Center, 2012* 79Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Erlangen-Nurnberg, 2012* 80List of FiguresInflammatory Bowel Disease Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 9Inflammatory Bowel Disease Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 10Inflammatory Bowel Disease Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 11Inflammatory Bowel Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012* 12Inflammatory Bowel Disease Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 13Inflammatory Bowel Disease Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 14Inflammatory Bowel Disease Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2012* 15Inflammatory Bowel Disease Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2012* 16Inflammatory Bowel Disease Therapeutics Clinical Trials, BRIC Countries (%), 2012* 17Inflammatory Bowel Disease Therapeutics Clinical Trials, G7 Countries (%), 2012* 18Inflammatory Bowel Disease Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 19Inflammatory Bowel Disease Therapeutics Clinical Trials, E7 Countries (%), 2012* 20Inflammatory Bowel Disease Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 21Inflammatory Bowel Disease Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 22Inflammatory Bowel Disease Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 23Inflammatory Bowel Disease Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 24Inflammatory Bowel Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011 32Inflammatory Bowel Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 33Inflammatory Bowel Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 35Inflammatory Bowel Disease Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 37GlobalData Methodology 214

To order this report:Drug_Discovery_and_Development Industry: Inflammatory Bowel Disease Global Clinical Trials Review, H2, 2012

Nicolas Bombourg

Reportlinker

Email: nicolasbombourg@reportlinker.com

US: (805)652-2626

Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Avaxia Biologics, Inc. Closes $4.1 Million Series A Financing to Advance Oral Antibodies for Inflammatory Bowel Disease
2. Avaxia Biologics, Inc. Raises $2.2 Million in First Closing of Series A Financing to Advance Oral Antibodies for Inflammatory Bowel Disease
3. Australian Discovered Biomarkers Map Path to New Blood Test for Bowel Cancer
4. Researchers unlock disease information hidden in genomes control circuitry
5. Micropharma Convenes Expert Roundtable on New Role for Probiotics in Cardiovascular Disease in time for National Cholesterol Education Month
6. New model of muscular dystrophy provides insight into disease development
7. Debiopharm Announces First Patient Enrolled in Phase III Study for the Rare Disease Central Precocious Puberty
8. Mosquitoes Common in the U.S. Can Transmit Disease-Causing Virus Endemic to Asia
9. Addisons Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics - Pipeline Assessment and Market Forecasts to 2019
10. Frost & Sullivan: Asia Pacific Infectious Disease Diagnostics Market Grows as Economies Boom and Countries Become Image Conscious
11. Synthetic Biologics and Intrexon Corporation Enter Worldwide Exclusive Collaboration for Infectious Diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2016)... , April 27, 2016 ... NSK) (OTCPink: NSKQB) ( Frankfurt : ... ihre Pressemitteilung vom 13. August 2015 die Genehmigung ... Finanzen um zusätzliche 200.000.000 Einheiten auf 400.000.000 Einheiten ... zu bringen. Davon wurden 157.900.000 Einheiten mit dem ...
(Date:4/27/2016)... Virgin Islands (PRWEB) , ... April 27, 2016 ... ... Company Ltd. (d/b/a Biohaven) is pleased to announce the appointment of John Tilton as ... was an Executive Director and one of the founding commercial leaders responsible for ...
(Date:4/27/2016)... MD (PRWEB) , ... April 27, 2016 , ... ... Greg Lamka, PhD to its Scientific Advisory Board. Dr. Lamka will assist PathSensors ... plant pathogen detection. , PathSensors deploys the CANARY® test platform for the ...
(Date:4/27/2016)... ... 2016 , ... Global Stem Cells Group CEO Benito Novas announced ... of GSCG affiliate Kimera Labs in Miami. , In 2004, Ross received his Ph.D. ... for hematologic disorders and the suppression of graft vs. host disease (GVHD) under UM ...
Breaking Biology Technology:
(Date:3/15/2016)... JERUSALEM , March 15, 2016 ... Jerusalem , the technology-transfer company of the Hebrew University, ... developer of remote sensing technology of various human biological ... funding, raising $2.0 million from private investors. ... technology, based on the detection of electromagnetic emissions from ...
(Date:3/11/2016)... 11, 2016 http://www.apimages.com ) - --> ... is available at AP Images ( http://www.apimages.com ) - ... used to produce the new refugee identity cards. DERMALOG will be ... CeBIT in Hanover next week.   --> ... be used to produce the new refugee identity cards. DERMALOG will ...
(Date:3/10/2016)... BLUE BELL, Pa. , March 10, 2016   ... U.S. Customs and Border Protection (CBP) is testing ... in San Diego to help identify ... United States . The test, designed to help determine ... outdoor, pedestrian environment, began in February and will run until ...
Breaking Biology News(10 mins):